Action brought on 21 April 2020 – Fidia farmaceutici v EUIPO – Ioulia and Irene Tseti Pharmaceutial Laboratories (HYAL)

(Case T-215/20)

Language of the case: English

Parties

Applicant: Fidia farmaceutici SpA (Abano Terme, Italy) (represented by: R. Kunz-Hallstein and H. Kunz-Hallstein, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Ioulia and Irene Tseti Pharmaceutial Laboratories SA (Athens, Greece)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: European Union word mark HYAL – European Union trade mark No 2 430 221

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 24 January 2020 in Case R 613/2019-5

Form of order sought

The applicant claims that the Court should:

annul the contested decision;

order EUIPO to pay the costs; in the alternative, if the other party before the Board of Appeal intervenes, order EUIPO and the intervener jointly and severally to pay the costs.

Pleas in law

Infringement of Article 165(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

Infringement of Articles 32(f) and 39(5) of Commission Delegated Regulation (EU) 2018/625;

Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

Infringement of Article 95(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

Infringement of Article 59(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

Infringement of Article 7(1)(c) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

____________